Cargando…
Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), are rising in both incidence and prevalence and remain a major global health and socioeconomic burden in the twenty-first century. Despite an increasing understanding of these diseases, the lack of effecti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588235/ https://www.ncbi.nlm.nih.gov/pubmed/36273156 http://dx.doi.org/10.1186/s12967-022-03693-0 |
_version_ | 1784814084052484096 |
---|---|
author | Chen, Yifei Yang, Fuji Chu, Ying Yun, Zhihua Yan, Yongmin Jin, Jianhua |
author_facet | Chen, Yifei Yang, Fuji Chu, Ying Yun, Zhihua Yan, Yongmin Jin, Jianhua |
author_sort | Chen, Yifei |
collection | PubMed |
description | Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), are rising in both incidence and prevalence and remain a major global health and socioeconomic burden in the twenty-first century. Despite an increasing understanding of these diseases, the lack of effective treatments remains an ongoing challenge. Mitochondria are key players in intracellular energy production, calcium homeostasis, signaling, and apoptosis. Emerging evidence shows that mitochondrial dysfunction participates in the pathogeneses of metabolic diseases. Exogenous supplementation with healthy mitochondria is emerging as a promising therapeutic approach to treating these diseases. This article reviews recent advances in the use of mitochondrial transplantation therapy (MRT) in such treatment. |
format | Online Article Text |
id | pubmed-9588235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95882352022-10-24 Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease Chen, Yifei Yang, Fuji Chu, Ying Yun, Zhihua Yan, Yongmin Jin, Jianhua J Transl Med Review Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), are rising in both incidence and prevalence and remain a major global health and socioeconomic burden in the twenty-first century. Despite an increasing understanding of these diseases, the lack of effective treatments remains an ongoing challenge. Mitochondria are key players in intracellular energy production, calcium homeostasis, signaling, and apoptosis. Emerging evidence shows that mitochondrial dysfunction participates in the pathogeneses of metabolic diseases. Exogenous supplementation with healthy mitochondria is emerging as a promising therapeutic approach to treating these diseases. This article reviews recent advances in the use of mitochondrial transplantation therapy (MRT) in such treatment. BioMed Central 2022-10-22 /pmc/articles/PMC9588235/ /pubmed/36273156 http://dx.doi.org/10.1186/s12967-022-03693-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Chen, Yifei Yang, Fuji Chu, Ying Yun, Zhihua Yan, Yongmin Jin, Jianhua Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title | Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title_full | Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title_fullStr | Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title_full_unstemmed | Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title_short | Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
title_sort | mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588235/ https://www.ncbi.nlm.nih.gov/pubmed/36273156 http://dx.doi.org/10.1186/s12967-022-03693-0 |
work_keys_str_mv | AT chenyifei mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease AT yangfuji mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease AT chuying mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease AT yunzhihua mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease AT yanyongmin mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease AT jinjianhua mitochondrialtransplantationopportunitiesandchallengesinthetreatmentofobesitydiabetesandnonalcoholicfattyliverdisease |